Accueil   Diary - News   All news EFS

EFS

Since January 1, 2000, EFS has been the only civil transfusion operator in France, under the supervision of the Ministry of Solidarity and Health.

 

Its main missions are to ensure self-sufficiency in blood products across the country, to guarantee the safety of the transfusion chain, from donor to recipient, and to help treat 1 million patients each year. In parallel with these missions, EFS Auvergne Rhône Alpes has developed a strong research activity covering fields of interest in the health sector with high translational potential: public health, infectious diseases and microbiology, immunology, regenerative medicine and transplantation.

 

For the past 5 years, EFS has been one of the main stakeholders in the development of advanced therapy medicinal products, with extensive expertise in the fields of regenerative medicine and immunotherapy.
Today, the EFS platform in Saint Ismier produces and controls clinical lots of cellular drugs for several Phase 1 and 2 clinical trials, in accordance with Good Manufacturing Practices. We are also project partners for the development, scale-up and transfer of MTI manufacturing processes in accordance with Good Manufacturing Practices.

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree